New Thyroid Assessment Tool, TNAPP, Eases Nodule Evaluation medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
email article
The FDA accepted a new drug application and set a review date of October 31 for Marius Pharmaceuticals Kyzatrex, an oral testosterone undecanoate softgel, for primary and secondary male hypogonadism.
The Endocrine Society released a new scientific statement calling for more research into the sex differences between males and females. (
Endocrine Reviews)
The American Medical Association has recognized a CPT code (category III) for laser ablation of benign thyroid nodules under imaging guidance, going into effect January 2022, National Ultrasound announced.
Entera Bio s oral human parathyroid hormone succeeded in a 6-month phase II trial at building bone in postmenopausal women with osteoporosis.
email article
The FDA approved fosdenopterin (Nulibry) the first specific treatment for the rare metabolic disorder molybdenum cofactor deficiency type A.
Hospitalized COVID-19 patients with low free T3 levels saw significantly higher rates of mortality, mechanical ventilation, and ICU admission. (
Endocrine Practice)
Almost a quarter of patients with kidney stone disease also had osteoporosis or a fracture, according to a study of over 500,000 people. (
Journal of Bone and Mineral Research)
In related news, women with primary ovarian insufficiency who experience early menopause have a higher risk for osteoporosis. This study . underscores the importance of the use of hormone therapy at least until the natural age of menopause in order to reduce the significant morbidity and mortality associated with osteoporotic fractures, commented Stephanie Faubion, MD, North American Menopause Society medical director. (